Prognosis of multiple myeloma patients based on histopathological evaluation of bone marrow.
Comparing to laboratory-based ISS, wider HR of death spectrum in this study proposes a potential more precise, robust and easy-to-use prognostication tool.
Authors
- Mohammad Ranaee (ORCID: https://orcid.org/0000-0002-7583-489X)
- Hoda Shirafkan (ORCID: https://orcid.org/0000-0002-5682-1153)
- Mohsen Vakili Sadeghi (ORCID: https://orcid.org/0000-0002-4415-6221)
- Housein Ghorbani
- Niloofar Arefi Sigaroudi
- Davood Jahansouz
Institutions
- Babol University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.22088/cjim.16.3.562
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77